Promoting Endogenous Cell Recruitment for Rotator Cuff Muscle Repair

促进内源性细胞募集以修复肩袖肌肉

基本信息

  • 批准号:
    10020758
  • 负责人:
  • 金额:
    $ 34.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Complete rotator cuff tears are a debilitating tendon injury that result in the atrophy and fatty degeneration of the corresponding muscle. Clinical outcomes following treatment of rotator cuff injuries are directly related to the quality of the rotator cuff muscle. Therefore, methods to reverse degenerative changes in the muscle would greatly improve overall outcomes for patients with rotator cuff tears. Due to the key relation between endogenous cell recruitment and tissue healing found in other types of muscle injury, we believe that the co-delivery of both stromal derived factor 1α (SDF-1α) and tumor necrosis factor-stimulated gene-6 (TSG-6) from glycosaminoglycan-based carriers tailored for each molecule will create a microenvironment in the rotator cuff muscle that will encourage recruitment and engraftment of anti-inflammatory macrophages and MSCs and therefore promote muscle regeneration after rotator cuff tendon tears. The objective of this application is to determine the relationship between local engraftment of bone marrow-derived cells and the level of regeneration of rotator cuff muscle after surgical repair of the torn tendon. This objective will be approached through the following specific aims: 1) Evaluate the effects of sustained release of SDF-1α on local cell recruitment and tissue regeneration in the rat supraspinatus muscle after tendon reattachment and 2)Evaluate the effects of co-release of SDF-1α and TSG-6 on local cell recruitment and tissue regeneration in the rat supraspinatus muscle after tendon reattachment. The proposed work is innovative because it employs a well-controlled, injectable carrier to achieve sustained release as well as enhance the effects of protein therapeutics to recruit endogenous cells in order to reverse muscle atrophy after rotator cuff tears. Results from these studies are expected to have an important positive impact because they will lead to more efficacious regenerative medicine therapies for rotator cuff tears, as well as provide greater mechanistic understanding of which cells participate in healing of degenerate muscle.
项目摘要 完全性肩袖撕裂是一种使人衰弱的肌腱损伤,导致肌肉萎缩和脂肪堆积。 相应肌肉的退化。肩袖损伤治疗后的临床结局 与肩袖肌肉的质量直接相关。因此,逆转退化的方法 肌肉的变化将大大改善肩袖撕裂患者的总体结局。由于 在其他类型的肌肉中发现的内源性细胞募集和组织愈合之间的关键关系 我们认为,基质衍生因子1α(SDF-1α)和肿瘤坏死因子(TNF-α) 来自为每个分子定制的基于糖胺聚糖的载体的因子刺激基因-6(TSG-6)将 在肩袖肌肉中创造一个微环境,以鼓励招募和植入 抗炎巨噬细胞和骨髓间充质干细胞,因此促进肌肉再生后旋转 肩袖肌腱撕裂。 本申请的目的是确定骨的局部植入之间的关系, 肩袖撕裂修复术后骨髓源性细胞与肩袖肌再生水平的关系 肌腱将通过以下具体目标实现这一目标:1)评估 持续释放SDF-1α对大鼠冈上肌局部细胞募集和组织再生的影响 2)评估SDF-1α和TSG-6的共同释放对局部肌松的影响, 肌腱再附着后冈上肌细胞募集和组织再生。 拟议的工作是创新的,因为它采用了一个控制良好的,可注射的载体,以实现 持续释放以及增强蛋白质治疗剂募集内源性细胞的作用, 以逆转肩袖撕裂后的肌肉萎缩。这些研究的结果预计将有 一个重要的积极影响,因为它们将导致更有效的再生医学疗法 对于肩袖撕裂,以及提供更大的机械理解,哪些细胞参与 退化肌肉的愈合。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Johnna S Temenoff其他文献

Johnna S Temenoff的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Johnna S Temenoff', 18)}}的其他基金

Biomaterials to enhance the efficacy of MSCs for rotator cuff repair
生物材料可增强 MSC 修复肩袖的功效
  • 批准号:
    10618264
  • 财政年份:
    2021
  • 资助金额:
    $ 34.4万
  • 项目类别:
Metabolomic Screening of Biomaterials for MSC Culture
用于 MSC 培养的生物材料的代谢组学筛选
  • 批准号:
    10396978
  • 财政年份:
    2021
  • 资助金额:
    $ 34.4万
  • 项目类别:
Promoting Endogenous Cell Recruitment for Rotator Cuff Muscle Repair
促进内源性细胞募集以修复肩袖肌肉
  • 批准号:
    10254285
  • 财政年份:
    2017
  • 资助金额:
    $ 34.4万
  • 项目类别:
Promoting Endogenous Cell Recruitment for Rotator Cuff Muscle Repair
促进内源性细胞募集以修复肩袖肌肉
  • 批准号:
    9755355
  • 财政年份:
    2017
  • 资助金额:
    $ 34.4万
  • 项目类别:
Injectable Biomaterials to Modulate Protease Activity in Tendinopathy
可注射生物材料调节肌腱病中的蛋白酶活性
  • 批准号:
    8725054
  • 财政年份:
    2013
  • 资助金额:
    $ 34.4万
  • 项目类别:
Injectable Biomaterials to Modulate Protease Activity in Tendinopathy
可注射生物材料调节肌腱病中的蛋白酶活性
  • 批准号:
    9119491
  • 财政年份:
    2013
  • 资助金额:
    $ 34.4万
  • 项目类别:
Injectable Biomaterials to Modulate Protease Activity in Tendinopathy
可注射生物材料调节肌腱病中的蛋白酶活性
  • 批准号:
    8578687
  • 财政年份:
    2013
  • 资助金额:
    $ 34.4万
  • 项目类别:
Co-Culture & Cyclic Tension to Direct Differentiation at Bone-Ligament Interface
共培养
  • 批准号:
    7530207
  • 财政年份:
    2008
  • 资助金额:
    $ 34.4万
  • 项目类别:
Graduate Training for Rationally Designed, Integrative Biomaterials - GT BioMAT
合理设计的综合生物材料研究生培训 - GT BioMAT
  • 批准号:
    9310010
  • 财政年份:
    2008
  • 资助金额:
    $ 34.4万
  • 项目类别:
Co-Culture & Cyclic Tension to Direct Differentiation at Bone-Ligament Interface
共培养
  • 批准号:
    7634496
  • 财政年份:
    2008
  • 资助金额:
    $ 34.4万
  • 项目类别:

相似海外基金

Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
  • 批准号:
    10727507
  • 财政年份:
    2023
  • 资助金额:
    $ 34.4万
  • 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
  • 批准号:
    9194162
  • 财政年份:
    2016
  • 资助金额:
    $ 34.4万
  • 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
  • 批准号:
    496858-2016
  • 财政年份:
    2016
  • 资助金额:
    $ 34.4万
  • 项目类别:
    University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
  • 批准号:
    9201955
  • 财政年份:
    2015
  • 资助金额:
    $ 34.4万
  • 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
  • 批准号:
    8251289
  • 财政年份:
    2014
  • 资助金额:
    $ 34.4万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8302750
  • 财政年份:
    2012
  • 资助金额:
    $ 34.4万
  • 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
  • 批准号:
    267940
  • 财政年份:
    2012
  • 资助金额:
    $ 34.4万
  • 项目类别:
    Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8403458
  • 财政年份:
    2012
  • 资助金额:
    $ 34.4万
  • 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
  • 批准号:
    8472443
  • 财政年份:
    2012
  • 资助金额:
    $ 34.4万
  • 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
  • 批准号:
    8549297
  • 财政年份:
    2012
  • 资助金额:
    $ 34.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了